Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER.

Sci Rep. 2019 Jun 14;9(1):8721. doi: 10.1038/s41598-019-44365-2.

2.

Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium.

Seano G, Nia HT, Emblem KE, Datta M, Ren J, Krishnan S, Kloepper J, Pinho MC, Ho WW, Ghosh M, Askoxylakis V, Ferraro GB, Riedemann L, Gerstner ER, Batchelor TT, Wen PY, Lin NU, Grodzinsky AJ, Fukumura D, Huang P, Baish JW, Padera TP, Munn LL, Jain RK.

Nat Biomed Eng. 2019 Mar;3(3):230-245. doi: 10.1038/s41551-018-0334-7. Epub 2019 Jan 7.

3.

Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach.

Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A.

Neuroradiology. 2019 May;61(5):545-555. doi: 10.1007/s00234-019-02173-5. Epub 2019 Feb 2.

PMID:
30712139
4.

Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.

Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER.

Sci Rep. 2018 Nov 20;8(1):17062. doi: 10.1038/s41598-018-34820-x. Erratum in: Sci Rep. 2019 Jun 14;9(1):8721.

5.

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery.

Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE.

Adv Radiat Oncol. 2018 May 17;3(4):559-567. doi: 10.1016/j.adro.2018.05.005. eCollection 2018 Oct-Dec.

6.

Towards patient-specific modeling of brain tumor growth and formation of secondary nodes guided by DTI-MRI.

Angeli S, Emblem KE, Due-Tonnessen P, Stylianopoulos T.

Neuroimage Clin. 2018 Aug 31;20:664-673. doi: 10.1016/j.nicl.2018.08.032. eCollection 2018.

7.

Brain-wide glymphatic enhancement and clearance in humans assessed with MRI.

Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SS, Emblem KE, Mardal KA, Eide PK.

JCI Insight. 2018 Jul 12;3(13). pii: 121537. doi: 10.1172/jci.insight.121537.

8.

Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?

Meling TR, Latysheva A, Da Broi M, Jahr G, Holte H Jr, Beiske K, Emblem KE.

Neuroradiology. 2018 Jul;60(7):703-713. doi: 10.1007/s00234-018-2038-9. Epub 2018 May 27.

PMID:
29804159
9.

Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes.

Eide PK, Vatnehol SAS, Emblem KE, Ringstad G.

Sci Rep. 2018 May 8;8(1):7194. doi: 10.1038/s41598-018-25666-4.

10.

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.

Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT.

NPJ Precis Oncol. 2017;1. pii: 20. doi: 10.1038/s41698-017-0020-3. Epub 2017 Jun 12.

11.

Non-invasive assessment of pulsatile intracranial pressure with phase-contrast magnetic resonance imaging.

Ringstad G, Lindstrøm EK, Vatnehol SAS, Mardal KA, Emblem KE, Eide PK.

PLoS One. 2017 Nov 30;12(11):e0188896. doi: 10.1371/journal.pone.0188896. eCollection 2017.

12.

A theoretical framework for determining cerebral vascular function and heterogeneity from dynamic susceptibility contrast MRI.

Digernes I, Bjørnerud A, Vatnehol SAS, Løvland G, Courivaud F, Vik-Mo E, Meling TR, Emblem KE.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2237-2248. doi: 10.1177/0271678X17694187. Epub 2017 Jan 1.

13.

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.

Kalpathy-Cramer J, Chandra V, Da X, Ou Y, Emblem KE, Muzikansky A, Cai X, Douw L, Evans JG, Dietrich J, Chi AS, Wen PY, Stufflebeam S, Rosen B, Duda DG, Jain RK, Batchelor TT, Gerstner ER.

J Neurooncol. 2017 Feb;131(3):603-610. doi: 10.1007/s11060-016-2332-5. Epub 2016 Nov 16.

PMID:
27853960
14.

Improving treatment of liver metastases by targeting nonangiogenic mechanisms.

Emblem KE, Jain RK.

Nat Med. 2016 Nov 8;22(11):1209-1210. doi: 10.1038/nm.4228. No abstract available.

PMID:
27824818
15.

Phase-contrast magnetic resonance imaging reveals net retrograde aqueductal flow in idiopathic normal pressure hydrocephalus.

Ringstad G, Emblem KE, Eide PK.

J Neurosurg. 2016 Jun;124(6):1850-7. doi: 10.3171/2015.6.JNS15496. Epub 2015 Dec 4.

PMID:
26636385
16.

MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly.

Heck A, Emblem KE, Casar-Borota O, Ringstad G, Bollerslev J.

Endocrine. 2016 Jul;53(1):327-30. doi: 10.1007/s12020-015-0816-2. Epub 2015 Nov 28. No abstract available.

PMID:
26615593
17.

Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.

Heck A, Emblem KE, Casar-Borota O, Bollerslev J, Ringstad G.

Endocrine. 2016 May;52(2):333-43. doi: 10.1007/s12020-015-0766-8. Epub 2015 Oct 16.

PMID:
26475495
18.

Reply: To PMID 25977480.

Ringstad G, Emblem KE, Geier O, Alperin N, Eide PK.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1633-4. doi: 10.3174/ajnr.A4488. Epub 2015 Aug 6. No abstract available.

PMID:
26251437
Free Article
19.

Impaired Verbal Learning Is Associated with Larger Caudate Volumes in Early Onset Schizophrenia Spectrum Disorders.

Juuhl-Langseth M, Hartberg CB, Holmén A, Thormodsen R, Groote IR, Rimol LM, Emblem KE, Agartz I, Rund BR.

PLoS One. 2015 Jul 31;10(7):e0130435. doi: 10.1371/journal.pone.0130435. eCollection 2015.

20.

Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy--Are We There Yet?

Gerstner ER, Emblem KE, Sorensen GA.

Cancer J. 2015 Jul-Aug;21(4):337-42. doi: 10.1097/PPO.0000000000000128. Review.

PMID:
26222087
21.

Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients.

Jafari-Khouzani K, Emblem KE, Kalpathy-Cramer J, Bjørnerud A, Vangel MG, Gerstner ER, Schmainda KM, Paynabar K, Wu O, Wen PY, Batchelor T, Rosen B, Stufflebeam SM.

Transl Oncol. 2015 Jun;8(3):137-46. doi: 10.1016/j.tranon.2015.03.002.

22.

Aqueductal Stroke Volume: Comparisons with Intracranial Pressure Scores in Idiopathic Normal Pressure Hydrocephalus.

Ringstad G, Emblem KE, Geier O, Alperin N, Eide PK.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1623-30. doi: 10.3174/ajnr.A4340. Epub 2015 May 14.

23.

Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.

Lu-Emerson C, Duda DG, Emblem KE, Taylor JW, Gerstner ER, Loeffler JS, Batchelor TT, Jain RK.

J Clin Oncol. 2015 Apr 1;33(10):1197-213. doi: 10.1200/JCO.2014.55.9575. Epub 2015 Feb 23.

24.

A generic support vector machine model for preoperative glioma survival associations.

Emblem KE, Pinho MC, Zöllner FG, Due-Tonnessen P, Hald JK, Schad LR, Meling TR, Rapalino O, Bjornerud A.

Radiology. 2015 Apr;275(1):228-34. doi: 10.1148/radiol.14140770. Epub 2014 Dec 8.

PMID:
25486589
25.

Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi O, Rosen B.

Cancer Res. 2014 Sep 1;74(17):4622-4637. doi: 10.1158/0008-5472.CAN-14-0383. Review.

26.

Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.

Emblem KE, Farrar CT, Gerstner ER, Batchelor TT, Borra RJ, Rosen BR, Sorensen AG, Jain RK.

Nat Rev Clin Oncol. 2014 Oct;11(10):566-84. doi: 10.1038/nrclinonc.2014.126. Epub 2014 Aug 12. Review.

27.

Machine learning in preoperative glioma MRI: survival associations by perfusion-based support vector machine outperforms traditional MRI.

Emblem KE, Due-Tonnessen P, Hald JK, Bjornerud A, Pinho MC, Scheie D, Schad LR, Meling TR, Zoellner FG.

J Magn Reson Imaging. 2014 Jul;40(1):47-54. doi: 10.1002/jmri.24390. Epub 2013 Nov 13.

PMID:
24753371
28.

Contrast-enhanced ultrasound identifies reduced overall and regional renal perfusion during global hypoxia in piglets.

Brabrand K, de Lange C, Emblem KE, Reinholt FP, Saugstad OD, Stokke ES, Munkeby BH.

Invest Radiol. 2014 Aug;49(8):540-6. doi: 10.1097/RLI.0000000000000053.

PMID:
24637585
29.

Identifying the central sulcus in patients with intra-axial lesions: a multicenter study comparing conventional presurgical MRI to topographical analysis and BOLD-fMRI.

Due-Tonnessen P, Rasmussen I, Berntsen EM, Bjornerud A, Emblem KE.

J Comput Assist Tomogr. 2014 Jan-Feb;38(1):1-8. doi: 10.1097/RCT.0b013e3182a589e0.

PMID:
24378889
30.

Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation.

Pinho MC, Polaskova P, Kalpathy-Cramer J, Jennings D, Emblem KE, Jain RK, Rosen BR, Wen PY, Sorensen AG, Batchelor TT, Gerstner ER.

Oncologist. 2014 Jan;19(1):75-81. doi: 10.1634/theoncologist.2013-0101. Epub 2013 Dec 5.

31.

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.

Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19059-64. doi: 10.1073/pnas.1318022110. Epub 2013 Nov 4.

32.

Age-related cortical thickness differences in adolescents with early-onset schizophrenia compared with healthy adolescents.

Thormodsen R, Rimol LM, Tamnes CK, Juuhl-Langseth M, Holmén A, Emblem KE, Rund BR, Agartz I.

Psychiatry Res. 2013 Dec 30;214(3):190-6. doi: 10.1016/j.pscychresns.2013.07.003. Epub 2013 Oct 19.

PMID:
24144503
33.

Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.

Emblem KE, Mouridsen K, Bjornerud A, Farrar CT, Jennings D, Borra RJ, Wen PY, Ivy P, Batchelor TT, Rosen BR, Jain RK, Sorensen AG.

Nat Med. 2013 Sep;19(9):1178-83. doi: 10.1038/nm.3289. Epub 2013 Aug 18.

34.

Comprehensive segmentation of subcortical brain volumes in early onset schizophrenia reveals limited structural abnormalities.

Juuhl-Langseth M, Rimol LM, Rasmussen IA Jr, Thormodsen R, Holmén A, Emblem KE, Due-Tønnessen P, Rund BR, Agartz I.

Psychiatry Res. 2012 Jul 30;203(1):14-23. doi: 10.1016/j.pscychresns.2011.10.005. Epub 2012 Aug 21.

PMID:
22917502
35.

SVM-based glioma grading: Optimization by feature reduction analysis.

Zöllner FG, Emblem KE, Schad LR.

Z Med Phys. 2012 Sep;22(3):205-14. doi: 10.1016/j.zemedi.2012.03.007. Epub 2012 Apr 13.

PMID:
22503911
36.

Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.

Sorensen AG, Emblem KE, Polaskova P, Jennings D, Kim H, Ancukiewicz M, Wang M, Wen PY, Ivy P, Batchelor TT, Jain RK.

Cancer Res. 2012 Jan 15;72(2):402-7. doi: 10.1158/0008-5472.CAN-11-2464. Epub 2011 Nov 29. Erratum in: Cancer Res. 2012 Jan 15;72(2):doi:10.1158/0008-5472.CAN-12-0113. Cancer Res. 2012 Mar 1;72(5):1316.

37.

Prefrontal hyperactivation during a working memory task in early-onset schizophrenia spectrum disorders: an fMRI study.

Thormodsen R, Jensen J, Holmèn A, Juuhl-Langseth M, Emblem KE, Andreassen OA, Rund BR.

Psychiatry Res. 2011 Dec 30;194(3):257-262. doi: 10.1016/j.pscychresns.2011.05.011. Epub 2011 Nov 12.

PMID:
22079661
38.

Multiparametric analysis of magnetic resonance images for glioma grading and patient survival time prediction.

Garzón B, Emblem KE, Mouridsen K, Nedregaard B, Due-Tønnessen P, Nome T, Hald JK, Bjørnerud A, Håberg AK, Kvinnsland Y.

Acta Radiol. 2011 Nov 1;52(9):1052-60. doi: 10.1258/ar.2011.100510. Epub 2011 Oct 3.

PMID:
21969702
39.

Cerebral perfusion in perinatal hypoxia and resuscitation assessed by transcranial contrast-enhanced ultrasound and 3 T MRI in newborn pigs.

de Lange C, Brabrand K, Emblem KE, Bjornerud A, Løberg EM, Saugstad OD, Munkeby BH.

Invest Radiol. 2011 Nov;46(11):686-96. doi: 10.1097/RLI.0b013e3182266431.

PMID:
21730873
40.

Assessment of pituitary adenoma volumetric change using longitudinal MR image registration.

Ringstad GA, Emblem KE, Holland D, Dale AM, Bjornerud A, Hald JK.

Neuroradiology. 2012 May;54(5):435-43. doi: 10.1007/s00234-011-0894-7. Epub 2011 Jun 7.

PMID:
21647587
41.

T1- and T2*-dominant extravasation correction in DSC-MRI: part I--theoretical considerations and implications for assessment of tumor hemodynamic properties.

Bjornerud A, Sorensen AG, Mouridsen K, Emblem KE.

J Cereb Blood Flow Metab. 2011 Oct;31(10):2041-53. doi: 10.1038/jcbfm.2011.52. Epub 2011 Apr 20.

42.

T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients.

Emblem KE, Bjornerud A, Mouridsen K, Borra RJ, Batchelor TT, Jain RK, Sorensen AG.

J Cereb Blood Flow Metab. 2011 Oct;31(10):2054-64. doi: 10.1038/jcbfm.2011.39. Epub 2011 Apr 20.

43.

Support vector machines in DSC-based glioma imaging: suggestions for optimal characterization.

Zöllner FG, Emblem KE, Schad LR.

Magn Reson Med. 2010 Oct;64(4):1230-6. doi: 10.1002/mrm.22495.

44.

A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI.

Bjørnerud A, Emblem KE.

J Cereb Blood Flow Metab. 2010 May;30(5):1066-78. doi: 10.1038/jcbfm.2010.4. Epub 2010 Jan 20.

45.

An automatic procedure for normalization of cerebral blood volume maps in dynamic susceptibility contrast-based glioma imaging.

Emblem KE, Bjornerud A.

AJNR Am J Neuroradiol. 2009 Nov;30(10):1929-32. doi: 10.3174/ajnr.A1680. Epub 2009 Jul 23.

46.

Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.

Emblem KE, Nedregaard B, Hald JK, Nome T, Due-Tonnessen P, Bjornerud A.

J Magn Reson Imaging. 2009 Jul;30(1):1-10. doi: 10.1002/jmri.21815.

PMID:
19557840
47.

Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging.

Emblem KE, Due-Tonnessen P, Hald JK, Bjornerud A.

Magn Reson Med. 2009 May;61(5):1210-7. doi: 10.1002/mrm.21944.

48.

Predictive modeling in glioma grading from MR perfusion images using support vector machines.

Emblem KE, Zoellner FG, Tennoe B, Nedregaard B, Nome T, Due-Tonnessen P, Hald JK, Scheie D, Bjornerud A.

Magn Reson Med. 2008 Oct;60(4):945-52. doi: 10.1002/mrm.21736.

49.

A piglet model for detection of hypoxic-ischemic brain injury with magnetic resonance imaging.

Munkeby BH, De Lange C, Emblem KE, Bjørnerud A, Kro GA, Andresen J, Winther-Larssen EH, Løberg EM, Hald JK.

Acta Radiol. 2008 Nov;49(9):1049-57. doi: 10.1080/02841850802334224.

50.

Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes.

Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1664-70. doi: 10.3174/ajnr.A1182. Epub 2008 Jun 26.

Supplemental Content

Loading ...
Support Center